Quick Answer
Sana Biotechnology, Inc. reported Stockholders Equity of $160.88 million for fiscal year 2025.
Sana Biotechnology, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $160.88M | -35.8% |
| 2024 | $250.50M | -12.9% |
| 2023 | $287.51M | -42.4% |
| 2022 | $499.31M | -31.5% |
| 2021 | $728.50M | +273.0% |
| 2020 | -$421.18M | -195.5% |
| 2019 | -$142.54M | -980.8% |
| 2018 | -$13.19M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $195.31M | -33.2% | +59.4% |
| June 30, 2025 | $122.56M | -63.9% | -41.4% |
| March 31, 2025 | $209.08M | -44.3% | -16.5% |
| December 31, 2024 | $250.50M | -12.9% | -14.4% |
| September 30, 2024 | $292.48M | -20.1% | -13.9% |
| June 30, 2024 | $339.65M | -4.3% | -9.5% |
| March 31, 2024 | $375.14M | -12.4% | +30.5% |
| December 31, 2023 | $287.51M | -42.4% | -21.4% |
- Sana Biotechnology, Inc. showed a decrease of -35.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Sana Biotechnology, Inc.’s stockholders equity has grown by 1319.9% (from -$13.19 million to $160.88 million).
- The most recent figure is from Sana Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: